Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Thursday November 5, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC Bulletin Board: CVAT) announced recently that it has signed Miura Engineering Co., Ltd. Tokyo, Japan (www.miura21.co.jp) as its new agent to serve markets in Japan for CTI’s Nano-Cavitation Process Systems. Miura is a leading Engineering Company specialized in Edible Oil Processing Plants in the Far East. Last week CVAT reported a 3-for-1 forward stock split.

At the 2nd Asia Pacific Contact Center Association Leaders and CCAM Expo this week in Kuala Lumpur, Malaysia, Convergys

...

There is suddenly a lot of interest in the idea that the federal government will make holding gold illegal, an example of which is “Is the Confiscation of Gold by Certain Central Banks Likely?” by Julian D. W. Phillips of GoldForecaster.com.

He reminds us that “in 1933 the US government banned the ownership of gold by US citizens and purchased all but rare gold coins from the US public. They did this, at $20 an ounce. Two years later they revalued gold to $35 an ounce, a 75% revaluation” which instantly gave the government a lot of new, but still 100% gold-backed money to spend!

What a blatant, brazen theft! And nobody says anything! But let me take a few bucks out of the employee pension fund, petty cash drawer or the coffee jar, then it is some kind of “big deal” around here and everyone wants me to get fired! What

...

Highlights include Gilead Sciences (GILD), AstraZeneca (AZN), Sanofi-Aventis (SNY) and Genzyme (GENZ).Last week, President Obama nominated Margaret "Peggy" Hamburg, a former New York City Health Commissioner, to lead the U.S. Food and Drug Administration (FDA). Hamburg's appointment must be confirmed by Congress. The president also named Baltimore Health Commissioner Joshua Sharfstein as FDA deputy commissioner.Hamburg earned her M.D. from Harvard Medical School and completed her training at the New York Hospital/Cornell University Medical Center. She did research in neuroscience at Rockefeller University in New York from 1985 to 1986, and in neuropharmacology at the National Institute of Mental Health in Bethesda, Maryland.From 1986 to 1988, she served in the U.S. Office of Disease Prevention and Health Promotion, and from 1989 to 1990 she was assistant director of the National Institute of Allergy and Infectious Diseases at NIH, where her ...

In 2002, the federal government created the Department of Homeland Security (DHS) to strengthen our nation’s security against acts of bioterrorism. Since its inception, the DHS has spent over $48 billion on a number of projects to keep citizens safe. One key component that the DHS has invested in is named BioWatch, a deployed system consisting of sensors placed in 30 undisclosed cities to detect airborne pathogens like anthrax, plague, and smallpox.

Some researchers are questioning the effectiveness of BioWatch. Theoretically, the sensors will detect threats and set off early-warning systems in DHS to ensure the earliest possible detection and deployment of personnel during a biological attack. However, a threat may take as long as 34 hours to detect since air samples are manually collected and physically taken to labs for analysis. A number of experts believe that a real-time detection system will

...

Gene Marcial, Busienss Week’s stock-picking guru recommended the following stocks which are tracked at:

http://trackthepros.com/

1. DELL

a.  CEO Michael Dell snapped up $100 million worth of the stock, bringing his stake to 12.8%. Dell’s unit sales jumped 19% in the second quarter, but a margin squeeze drove the stock down.

b. Dell is now focused on fattening margins and boosting profits by cost-cutting and other means, rather than just concentrating on gaining market share.  It has fixed major problems it faced 18 months ago, he says, such as improving the quality of its products and services.

c. Balance sheet and cash flow remain strong, with $1.1 billion in cash flow from operations in the second quarter and $9.5 billion in cash at quarter’s end.

2. Why Goodyear Could Get Traction

a.  Goodyear Tire & Rubber shares have fallen to 17.32, down from a 52-week high of 31.36 last October.

b. Goodyear has been doing

...

TapImmune Inc. (TPIM.OB) recently announced that an independent third-party research group published an article in the Journal of Investigative Dermatology confirming that a TapImmune (TAP) vaccine should be considered as a therapy for treating Melanoma based cancer. The National Cancer Institute has forecasted that within the next five years cancer will be ranked as the number one cause of death by illness of Americans.

The company’s TAP vaccine against cancer helps the body move cancer makers to the surface of cells to allow a person’s body to detect and fight the cancerous cells. Initially developed at The University of British Columbia, the preclinical trials for melanoma and lung carcinoma in animal subjects show positive results. A 70% survival rate was achieved in test subjects when using the TAP vaccine therapy, while a 100% survival rate was achieved when the TAP was administered ex-vivo.

The TAP vaccine has also shown success

...